Skip to main content
Journal ArticleOPEN ACCESS

Lipid metabolism dysfunction in progranulin mutation carriers: Unbiased metabolomics reveals strong relationship to clinical status in FTLD

  • Vandevrede L
  • Rojas J
  • et al.
Alzheimer's & Dementia (2020) 16(S5)
DOI: 10.1002/alz.046594
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Heterozygous progranulin (GRN) mutations are an important cause of

Cite

CITATION STYLE

APA

Vandevrede, L., Rojas, J. C., Wang, P., Heuer, H. W., Karydas, A. M., … Boxer, A. L. (2020). Lipid metabolism dysfunction in progranulin mutation carriers: Unbiased metabolomics reveals strong relationship to clinical status in FTLD. Alzheimer’s & Dementia, 16(S5). https://doi.org/10.1002/alz.046594

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free